Axel Roth

Axel Roth has extensive experience in product development and device development in the pharmaceutical industry. From 2010 to 2014, they worked at sanofi-aventis as the Head of Blood Glucose Monitoring Development Projects. Axel then joined Boehringer Ingelheim in 2014, where they initially worked in device development and later became the Head of Device/Combination Product Development for parenteral products. In 2020, they moved to Stevanato Group, Balda Medical, where they currently hold the position of Head of Product Development Drug Delivery Systems.

Axel Roth attended the University of Sussex and TU Darmstadt, but the specific years and degrees obtained are not provided. Axel later pursued a DPhil in Mathematics & Mechanical Engineering at the University of Sussex.